EWTX compared with RYTM: revenue, margins and what each company keeps, and the suppliers and customers both name

EWTXEdgewise Therapeutics, Inc.

Mkt capRevenueRevenue

RYTMRhythm Pharmaceuticals, Inc.

Mkt capRevenueRevenue

Compare

EWTXEdgewise Therapeutics, Inc.

RYTMRhythm Pharmaceuticals, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Co-movers

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Co-movers

daily closes · 500dMethod ›

Moved together

EWTXwithRYTM

×0.19co-movement · RYTM on EWTX · 500d

r 0.26scale to r 0.75

Shared co-movers2with EWTXwith RYTM

RCUSArcus Biosciences, Inc.r 0.30r 0.34

NRIXNurix Therapeutics, Inc.r 0.29r 0.34

EWTX, solidRYTM, hatched× = co-movement · βr = correlationBar = r to r 0.75Order: weaker of A and BSource: daily closes

EWTXEdgewise Therapeutics, Inc.

38.93▲+0.04%· post 39.06

Mkt cap$4.2BRevenue—Revenue—

RYTMRhythm Pharmaceuticals, Inc.

91.74▼−1.43%· post 91.74

ClosedOct 30 '26

Mkt cap$6.4BRevenue$71MQ2 FY26Revenue$190MFY25

Compare

ClosedOct 30 '26

EWTXEdgewise Therapeutics, Inc.

RYTMRhythm Pharmaceuticals, Inc.

38.93▲+0.04%post 39.06

Price

91.74▼−1.43%post 91.74

$4.2B

Mkt cap

$6.4B

—

Revenue

$71MQ2 FY26

—

Revenue

$190MFY25

EWTX38.93▲+0.04%vsRYTM91.74▼−1.43%ClosedOct 30 '26